Analysis of the correlation between the immune signatures of pancreatic cancer and PIM1, PIM2, and PIM3 revealed that PIM expression was significantly correlated with higher MAPK activation scores, T-cell inflammation scores, inflammatory markers, MHC class I and II gene expression, and various immune cell infiltrations. The gene discussed is PIM2; the disease is familial pancreatic carcinoma.